Mohammad K. Khan, MD, PhD, MS

Board certified in radiobiology/physics by the American Board of Radiology, Mohammad Khan, MD, PhD, MS, FACRO, FACR, DABR, specializes in the treatment of lymphoma, leukemia, multiple myeloma, skin (melanoma, squamous cell, basal cell, merkel cell), and pediatric cancers. Dr. Khan serves as vice chair for education in the Department of Radiation Oncology where he works to complement and extend the department's educational efforts beyond its residency programs.

Dr. Khan fluently speaks English, Urdu, Hindi and is familiar with Spanish and Arabic.

Dr. Khan is a sought-after subject matter expert on low-dose radiotherapy and other radiation oncology topics. He has appeared on a number of media outlets, including CNN, Forbes, and WebMD.

Prior to medical school, Dr. Khan received two BS degrees, one in Nuclear Engineering and one in Biology with a minor in Biochemistry and Molecular Biology. Both degrees were awarded with Summa Cum Laude distinction. He then completed his MS, and PhD degrees in Nuclear Engineering with emphasis on health and medical physics from the University of Tennessee, Knoxville. His graduate research focused on the use of innovative imaging technologies, such as PET and MRI, to improve radiation treatment planning for emerging cancer therapeutics such as boron neutron capture therapy for patients with malignant brain tumors. 

Dr. Khan did his residency training in radiation oncology at the Cleveland Clinic, Cleveland, OH. He completed a fellowship in ABS Prostate Bracytherapy at the Seattle Prostate Institute and an internship in medicine and surgery at the Cleveland Clinic.

Dr. Khan is a fellow and member of the American College of Radiation Oncology. He also holds professional memberships with American College of Radiology, American Brachytherapy Society, American Society for Therapeutic Radiation Oncology and American Society of Clinical Oncology. He serves as a board member of the Georgia Radiological Society; is a vice chair of the Radiation Safety Committee for Human Use at Emory; and is an active member of the ACRIN/ECOG melanoma committee. He is also the Panel Chair for the leukemia/lymphoma section of the Radiation Oncology In-Training Examination (TXIT™) program at the American College of Radiology. He also serves on the radiation oncology exam committee of the American Board of Radiology where he is involved developing maintenance of certification exam questions, initial certification exam questions, and oral exam questions as they relate to the management of lymphoma, leukemia, and myeloma patients.

To provide the highest quality of care, interpreter services may be utilized to ensure proper communication of medical information for deaf, hard-of-hearing, and non-English speaking patients or family members.

Dr. Khan has received a number of awards and honors including the following:

• Top Doctors “Best of Best” Award for multiple years of recognition, Atlanta Magazine, 2024
• Educators Appreciation Award, Emory University School of Medicine, 2024
• Innovations for Impact Award, Emory University School of Medicine, 2024
• Department of Radiation Oncology Mentorship Award, Emory University School of Medicine, 2024
• Department of Radiation Oncology Service Award, Emory University School of Medicine, 2024
• Atlanta Magazine Top Doctors, 2021, 2022, 2023, 2024
• Basic and Translational Sciences Research Award, ASTRO, 2023 
• Leadership and Service Award, GA-APPNA, 2023
• Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who, 2021
• Volunteer Service Award, ABR, 2020
• Outstanding Mentorship Award, Winship Cancer Institute of Emory Unviersity, 2018
• Top Doctors Award for Top Radiation Oncologist in Atlanta, 2017
• Winship 5K Research Scholar Award, Winship Cancer Institute of Emory University, 2016
• Top Doctor in Atlanta, International Association of Radiologists, 2014, 2016

During his residency training, he received several academic accolades including the Roentgen Resident/Fellow Research Award for Outstanding Radiological Research, the Scott Hamilton CARES Initiative Research Grant to fund a prospective phase I prostate cancer IGRT study, American College of Radiation Oncology Travel Award, American Brachytherapy Society Fellowship Award, and the American Society of Therapeutic Radiation Oncology Translation and Imaging Symposium Travel Award.